Smith Darren Charlton (CIK 2122447) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-14). Recent activity: Buy TLX (2,071 shares), Buy TLX (1,111 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Telix Pharmaceuticals Ltd (TLX) | Group Chief Financial Officer | Buy | 2,071 | $19,998 |
| 2026-04-01 | Telix Pharmaceuticals Ltd (TLX) | Group Chief Financial Officer | Buy | 1,111 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14